Reducing SARS-CoV-2 False Positives LC-MS Protein Detection

The SARS-CoV-2 pandemic has spurred rapid innovation in donor testing and prognostic biomarker reliability. This webcast will describe a comprehensive
LC-MS based assay for detecting and quantifying critical proteins from nasopharyngeal swab and plasma samples to confirm RT-PCR test results and assess disease severity.

You will learn:

How to ensure high confidence in identification and sequencing protein-specific peptides that are moved to targeted methods
Establishing verification metrics for targeted peptide detection and quantification for infectious disease analysis
The importance of determining viral load in assessing health aspects

About the presenter

Dr. Sanjeeva Srivastava
Professor, Department of Biosciences and Bioengineering

Group Head, Proteomics Facility, Indian Institute of Technology Bombay, Mumbai Sanjeeva Srivastava, FRSB, FRSC, FRSM, obtained his Ph.D. from University of Alberta, his post-doc from Harvard Medical School and joined Indian Institute of Technology (IIT) Bombay, Mumbai where he is currently a full Professor. His research on protein biomarkers of infectious diseases and brain tumors has resulted in 120+ publications and over 20 patents filed.

Register to view the free
on-demand webinar

* Required field

First Name

Last Name

Company

Business Phone

Street Address

City

Postal Code/Zip

I would like to speak with an sales representative to learn how Thermo Fisher Scientific products can help in my laboratory

Please confirm you would like to receive marketing and promotional email messages about Thermo Fisher Scientific products and services.

Resources

Support

Blog: LCMS for detecting COVID-19 in clinical research

On-Demand Webinar: Reducing SARS-CoV-2 False Positives Using LC-MS Methods for Viral and Host Protein Detection